Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study)

References

• Zhu N, Zhang D, Wang W, et al.; China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• Instituto de Salud Carlos III. COVID-19 in Spain. 2020. https://cnecovid.isciii.es/covid19
   Google Scholar
• Kavsak PA, de Wit K, Worster A. Emerging key laboratory tests for patients with COVID-19. Clin Biochem. 2020;81:13–14.
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Hou YL, Li DT, et al. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Invest. 2020;80(6):441–447.
   PubMed Web of Science ®Google Scholar
• Thompson S, Bohn MK, Mancini N, et al.; IFCC Taskforce on COVID-19. IFCC interim guidelines on biochemical/hematological monitoring of COVID-19 patients. Clin Chem Lab Med. 2020;58(12):2009–2016.
   PubMed Web of Science ®Google Scholar
• Wadhera RK, Wadhera P, Gaba P, et al. Variation in COVID-19 hospitalizations and deaths across New York City Boroughs. Jama. 2020;323(21):2192–2195.
   PubMed Web of Science ®Google Scholar
• Panteghini M. Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only). Clin Chem Lab Med. 2020;58(12):1979–1981.
   PubMed Web of Science ®Google Scholar
• van der Burg SH, Kalos M, Gouttefangeas C, et al. Harmonization of immune biomarker assays for clinical studies. Sci Transl Med. 2011;3(108):108ps44–108ps44.
   PubMed Web of Science ®Google Scholar
• Ricós C, Fernández-Calle P, Marqués F, et al. Impact of implementing a category 1 external quality assurance scheme for monitoring harmonization of clinical laboratories in Spain. Advances in Laboratory Medicine/Avances en Medicina de Laboratorio. 2020;1:20200008.
   Google Scholar
• Kurstjens S, van der Horst A, Herpers R, et al. Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing. Clin Chem Lab Med. 2020;58(9):1587–1593.
   PubMed Web of Science ®Google Scholar
• Favaloro EJ, Thachil J. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation. Clin Chem Lab Med. 2020;58(8):1191–1199.
   PubMed Web of Science ®Google Scholar
• Neeser O, Branche A, Mueller B, et al. How to: implement procalcitonin testing in my practice. Clin  Microbiol Infect. 2019;25(10):1226–1230.
   PubMed Web of Science ®Google Scholar
• Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131.
   PubMed Web of Science ®Google Scholar
• Sarangi R, Pathak M, Padhi S, et al. Ferritin in hemophagocytic lymphohistiocytosis (HLH): current concepts and controversies. Clin Chim Acta. 2020;510:408–415.
   PubMed Web of Science ®Google Scholar
• Kermali M, Khalsa RK, Pillai K, et al. The role of biomarkers in diagnosis of COVID-19 - A systematic review . Life Sci. 2020;254:117788.
   PubMed Web of Science ®Google Scholar
• Berenguer J, Ryan P, Rodríguez-Baño J, et al.; Centro Nacional de Epidemiología. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain . Clin Microbiol Infect. 2020;26(11):1525–1536.
   PubMed Web of Science ®Google Scholar
• Gil-Rodrigo A, Miró Ò, Piñera P, et al. en representación de la red de investigación SIESTA. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments. Emergencias. 2020;32:233–241.
   PubMed Web of Science ®Google Scholar
• Casas-Rojo JM, Antón-Santos JM, Millán-Núñez-Cortés J, et al.; en nombre del Grupo SEMI-COVID-19 Network. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clin Esp. 2020;220(8):480–494.
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, et al. China medical treatment expert group for covid-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720.
   PubMed Web of Science ®Google Scholar
• Kim L, Garg S, O'Halloran A, et al. Risk factors for intensive care unit admission and In-hospital mortality among hospitalized adults identified through the U.S. coronavirus disease 2019 (COVID-19)-associated hospitalization surveillance network (COVID-NET). Clin Infect Dis. 2020;ciaa1012.
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, ISARIC4C investigators, et al. ISARIC4C investigators. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985.
   PubMed Web of Science ®Google Scholar
• Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. Jama. 2020;323(18):1775–1776.
   PubMed Web of Science ®Google Scholar
• Bonanad C, García-Blas S, Tarazona-Santabalbina F, et al. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21(7):915–918.
   PubMed Web of Science ®Google Scholar
• Jin JM, Bai P, He W, et al. Gender differences in patients with COVID-19: focus on severity and mortality. Front Public Health. 2020;8:152.
   PubMed Web of Science ®Google Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang Q, Chi J, et al. Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. Int J Infect Dis. 2020;99:47–56.
   PubMed Web of Science ®Google Scholar
• Pugliese G, Vitale M, Resi V, et al. Is diabetes mellitus a risk factor for Corona virus disease 19 (COVID-19)? Acta Diabetol. 2020;57(11):1275–1211.
   PubMed Web of Science ®Google Scholar
• Plebani M. Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med. 2013;51(4):741–751.
   PubMed Web of Science ®Google Scholar
• Aloisio E, Serafini L, Chibireva M, et al. Hypoalbuminemia and elevated D-dimer in COVID-19 patients: a call for result harmonization. Clin Chem Lab Med. 2020;58(11):e255–e256.
   PubMed Web of Science ®Google Scholar
• Bermejo-Martin JF, Almansa R, Menéndez R, et al. Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection. J Infect. 2020;80(5):e23–e24.
   PubMed Web of Science ®Google Scholar
• Wang J, Jiang M, Chen X, et al. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J Leukoc Biol. 2020;108(1):17–41.
   PubMed Web of Science ®Google Scholar
• Bahl A, Van Baalen MN, Ortiz L, et al. Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort. Intern Emerg Med. 2020;15(8):1485–1415.
   PubMed Web of Science ®Google Scholar
• Gaze DC. Clinical utility of cardiac troponin measurement in COVID-19 infection. Ann Clin Biochem. 2020;57(3):202–205.
   PubMed Web of Science ®Google Scholar
• Sahu BR, Kampa RK, Padhi A, et al. C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta. 2020;509:91–94.
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020;506:145–148.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Fukushima EA, Levine M, et al. Predictors for Severe COVID-19 Infection. Clin Infect Dis. 2020;71(8):1962–1968.
   PubMed Web of Science ®Google Scholar
• Albini A, Di Guardo G, Noonan DM, et al. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies. Intern Emerg Med. 2020;15(5):759–766.
   PubMed Web of Science ®Google Scholar
• Roncon L, Zuin M, Zonzin P. Age-adjusted D-dimer cut-off levels to rule out venous thromboembolism in COVID-19 patients. Thromb Res. 2020;190:102.
   PubMed Web of Science ®Google Scholar
• Laguna-Goya R, Utrero-Rico A, Talayero P, et al. IL-6-based mortality risk model for hospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(4):799–807.e9.
   PubMed Web of Science ®Google Scholar